Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Claude Nicaise currently holds 31,532 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Claude Nicaise has been a net neutral trader of SRPT stock. They have purchased $0 and sold $0 worth of shares.
Claude Nicaise's most recent insider trade was on Jan 29, 2026, when they sold 10,500 shares at $0.00 per share.
Claude Nicaise serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 15 insider transactions totaling $0 over their tenure at the company.
Claude Nicaise holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Claude Nicaise has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Claude Nicaise was on Jan 29, 2026, when they sold $144.0K worth of SRPT shares. This transaction involved 10,500 shares at $13.71 per share.
Claude Nicaise currently owns 31,532 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Claude Nicaise's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Claude Nicaise has 15 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Claude Nicaise and 40,000+ other insiders.